Depression changes your brain, decreasing nerve activity in the areas responsible for regulating your mood.
Depression changes your brain, decreasing nerve activity in the areas responsible for regulating your mood.
At BrainCare Carlsbad, we harness the power of magnetic stimulation to relieve your depression symptoms.
• rTMS uses magnetic fields to stimulate nerve cells in the brain, improving symptoms of depression. Read more about rTMS here.
• MeRT, on the other hand, is a personalized form of treatment that tailors the approach to your unique brain wave patterns. Read more about MeRT here.
MeRT and rTMS use magnetic impulses to stimulate the underperforming brain areas and restore normal nerve activity. As your brain function improves, so does your depression.
Many studies have shown the effectiveness of rTMS in reducing depression symptoms. Here are three of the most recent:
• A 2023 meta-analysis of randomized sham-controlled trials found that rTMS was significantly more effective than its sham counterpart in treating Treatment-Resistant Depression (TRD) in patients with Major Depressive Disorder (MDD) who had experienced two treatment failures.
“The results of this meta-analysis… proved that rTMS treatment may be used effectively in the treatment of TRD, as it offers the possibility of achieving not only a symptomatic response, but also a complete remission in patients, who respond well to the treatment.”
• An October 2022 meta-analysis studied 65 randomized controlled trials, gathering data from nearly 3,000 patients. They confirmed that rTMS is effective in treating depression symptom reduction, response, and remission.
“In summary, our results are clinically relevant and support the use of rTMS as a non-invasive and effective treatment option for different levels of treatment resistant depression.”
• A June 2022 review of 17 randomized controlled trials showed rTMS to be effective, safe, and well tolerated in depression treatment, with significant symptom relief.
“For patients with TRD, rTMS appears to provide significant benefits through the reduction of depressive symptoms…”
The science and protocols behind rTMS and MeRT® are based on years of authoritative research published in some of the most prestigious scientific journals. Here are just some of these.
“This data provides a demonstration of significant reduction in PTSD and depression symptoms and safety with the application of a-rTMS in active-duty special operations military personnel. Expansion of targeted neuromodulation programs could be impactful for military and civilian populations.”
“Several meta-analyses proved the efficacy of rTMS treatment in MDD, which is comparable to pharmacotherapy, and may have even better tolerability. Our results strengthened that rTMS is associated with clinically relevant antidepressant effect in TRD as well, and may be a beneficial tool in the add-on treatment of patients with TRD. Furthermore, rTMS adjunctive treatment to antidepressants was found to be specifically effective in achieving full remission.”
“Overall, 16 out of the 17 studies suggested that rTMS treatment was effective, safe and tolerated in TRD. For patients with TRD, rTMS appears to provide significant benefits through the reduction of depressive symptoms…”
“Data from nearly 3000 patients from 65 randomized controlled trials were included in this meta-analysis. rTMS was confirmed as efficacious in treating depression when looking at symptom reduction, response and remission.”
Experimental depression treatment is nearly 80% effective in controlled study (October 28, 2021)
“In a double-blind controlled study, high doses of magnetic brain stimulation, given on an accelerated timeline and individually targeted, caused remission in 79% of trial participants with severe depression.
“A new type of magnetic brain stimulation brought rapid remission to almost 80% of participants with severe depression in a study conducted at the Stanford University School of Medicine.
“rTMS is rapidly gaining popularity as a treatment modality for depression. There is growing evidence to support its use in patients with depression as a monotherapy or as adjunct with pharmacotherapy. Additionally, rTMS has been found to be safe and effective in pregnant patients and elderly patients…”
Use of Transcranial Magnetic Stimulation for Depression (May 2019)
“The clinical efficacy of TMS as an antidepressant has been well established. TMS is an innovative and promising treatment modality for patients with TRD [treatment-resistent depression].”
This study found: “Conclusion: These data confirm that TMS is effective in the acute treatment of MDD in routine clinical practice settings. This symptom benefit is accompanied by statistically and clinically meaningful improvements in patient-reported QOL [quality of life] and functional status outcomes.”
“These data indicate that TMS is an effective treatment for those unable to benefit from initial antidepressant medication.”